CHLORAPREP TRIPLE SWABSTICK
LOE Approachingchlorhexidine gluconate and isopropyl alcohol
NDATOPICALSWAB
Approved
Oct 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CHLORAPREP TRIPLE SWABSTICK (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2002.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLORAPREP TRIPLE SWABSTICK is a topical antimicrobial swab containing chlorhexidine gluconate and isopropyl alcohol used for skin antisepsis prior to medical procedures. It provides rapid bactericidal activity through dual-agent formulation designed to reduce surgical site infections. The triple swab format enables comprehensive skin preparation with three sequential applications.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting transition planning and potential team restructuring ahead.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
CHLORAPREP TRIPLE SWABSTICK offers limited career growth given its LOE-approaching lifecycle and zero linked job openings; roles focus on operational efficiency and market defense rather than innovation. Career prospects improve if you seek stable, established portfolio management in a mature category with predictable revenue streams.
Product Manager
Worked on CHLORAPREP TRIPLE SWABSTICK at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.